These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
535 related articles for article (PubMed ID: 11362329)
1. Sulfasalazine: arthritis drug increases CD4 count? Smith D AIDS Treat News; 1995 Mar; (no 218):6-7. PubMed ID: 11362329 [TBL] [Abstract][Full Text] [Related]
2. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART. Isgrò A; Leti W; De Santis W; Marziali M; Esposito A; Fimiani C; Luzi G; Pinti M; Cossarizza A; Aiuti F; Mezzaroma I Clin Infect Dis; 2008 Jun; 46(12):1902-10. PubMed ID: 18462177 [TBL] [Abstract][Full Text] [Related]
3. Granulocyte/monocyte apheresis induces sustained increases in CD4 T cells in HIV-1 infected patients with poor CD4 T cell restoration after suppression of viral replication by HAART. Hasson H; Saniabadi A; Alfano M; Trabattoni D; Ferrante P; Lillo F; Clerici M; Lazzarin A; Beretta A J Biol Regul Homeost Agents; 2002; 16(1):58-63. PubMed ID: 12003176 [TBL] [Abstract][Full Text] [Related]
4. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy. Smith CJ; Sabin CA; Youle MS; Kinloch-de Loes S; Lampe FC; Madge S; Cropley I; Johnson MA; Phillips AN J Infect Dis; 2004 Nov; 190(10):1860-8. PubMed ID: 15499544 [TBL] [Abstract][Full Text] [Related]
5. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART. Aiuti F; Mezzaroma I AIDS Rev; 2006; 8(2):88-97. PubMed ID: 16848276 [TBL] [Abstract][Full Text] [Related]
6. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells. López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792 [TBL] [Abstract][Full Text] [Related]
7. The immune response to AIDS virus infection: good, bad, or both? Deeks SG; Walker BD J Clin Invest; 2004 Mar; 113(6):808-10. PubMed ID: 15067312 [TBL] [Abstract][Full Text] [Related]
8. Cytokine profile in human immunodeficiency virus positive patients with and without tuberculosis. Agarwal SK; Singh A; Anuradha S; Singh NP; Sokhi J; Baveja UK J Assoc Physicians India; 2001 Aug; 49():799-802. PubMed ID: 11837467 [TBL] [Abstract][Full Text] [Related]
9. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124 [TBL] [Abstract][Full Text] [Related]
10. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Moore RD; Keruly JC Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456 [TBL] [Abstract][Full Text] [Related]
11. Outrunning HIV to protect immune defenses. Gilden D GMHC Treat Issues; 1996 Nov; 10(11):1-5. PubMed ID: 11364008 [TBL] [Abstract][Full Text] [Related]
12. Antioxidants may still have a role in HIV treatment. Chan G; Collins J; Horn T GMHC Treat Issues; 1997 Sep; 11(9):6-12. PubMed ID: 11364752 [TBL] [Abstract][Full Text] [Related]
13. Impact of acute vivax malaria on the immune system and viral load of HIV-positive subjects. Chen X; Xiao B; Shi W; Xu H; Gao K; Rao J; Zhang Z Chin Med J (Engl); 2003 Dec; 116(12):1810-20. PubMed ID: 14687465 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-7 (IL-7): immune function, involvement in the pathogenesis of HIV infection and therapeutic potential. Beq S; Delfraissy JF; Theze J Eur Cytokine Netw; 2004; 15(4):279-89. PubMed ID: 15627636 [TBL] [Abstract][Full Text] [Related]
15. HIV surrogate markers: new virologic and immunologic indicators. MacDougall DS J Int Assoc Physicians AIDS Care; 1997 Mar; 3(3):15-7. PubMed ID: 11364123 [TBL] [Abstract][Full Text] [Related]
16. Use and access to viral load measure assays: the need for validation. Agosto M Update Natl Minor AIDS Counc; 1995; ():7-8. PubMed ID: 11362791 [TBL] [Abstract][Full Text] [Related]
17. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
18. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M; Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216 [TBL] [Abstract][Full Text] [Related]
19. Treatment of Schistosoma mansoni infection increases helminth-specific type 2 cytokine responses and HIV-1 loads in coinfected Ugandan adults. Brown M; Mawa PA; Joseph S; Bukusuba J; Watera C; Whitworth JA; Dunne DW; Elliott AM J Infect Dis; 2005 May; 191(10):1648-57. PubMed ID: 15838791 [TBL] [Abstract][Full Text] [Related]